Cassava Sciences Inc. (SAVA) Financial Statements (2024 and earlier)

Company Profile

Business Address 6801 N CAPITAL OF TEXAS HIGHWAY
AUSTIN, TX 78731
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments124,169,000121,136,000142,350,000168,438,000187,467,000201,015,000
Cash and cash equivalents124,169,000121,136,000142,350,000168,438,000187,467,000201,015,000
Receivables1,000,000962,0001,285,0001,328,000  
Prepaid expense382,000759,0001,136,000240,000716,0001,034,000
Other current assets218,000287,000189,000   
Other undisclosed current assets8,230,0006,489,0005,224,0004,527,0006,816,0009,177,000
Total current assets:133,999,000129,633,000150,184,000174,533,000194,999,000211,226,000
Noncurrent Assets
Operating lease, right-of-use asset      122,000
Property, plant and equipment21,604,00021,854,00022,077,00022,328,00022,609,00022,864,000
Intangible assets, net (including goodwill)115,000176,000268,000387,000503,000622,000
Intangible assets, net (excluding goodwill)115,000176,000268,000387,000503,000622,000
Total noncurrent assets:21,719,00022,030,00022,345,00022,715,00023,112,00023,608,000
TOTAL ASSETS:155,718,000151,663,000172,529,000197,248,000218,111,000234,834,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities228,000200,000187,00017,382,00013,518,0006,297,000
Accounts payable    10,338,0008,242,0004,017,000
Accrued liabilities228,000200,000187,0007,044,0005,276,0002,280,000
Derivative instruments and hedges, liabilities 65,368,000     
Other liabilities125,000385,000391,000293,000179,000492,000
Other undisclosed current liabilities11,400,00013,610,00016,836,000220,000212,000274,000
Total current liabilities:77,121,00014,195,00017,414,00017,895,00013,909,0007,063,000
Noncurrent Liabilities
Liabilities, other than long-term debt     197,000232,000
Other liabilities     197,000197,000
Operating lease, liability      35,000
Total noncurrent liabilities:     197,000232,000
Total liabilities:77,121,00014,195,00017,414,00017,895,00014,106,0007,295,000
Equity
Equity, attributable to parent78,597,000137,468,000155,115,000179,353,000204,005,000227,539,000
Common stock43,00042,00042,00042,00042,00042,000
Additional paid in capital434,280,000518,195,000514,923,000513,510,000511,786,000511,049,000
Accumulated deficit(355,726,000)(380,769,000)(359,850,000)(334,199,000)(307,823,000)(283,552,000)
Total equity:78,597,000137,468,000155,115,000179,353,000204,005,000227,539,000
TOTAL LIABILITIES AND EQUITY:155,718,000151,663,000172,529,000197,248,000218,111,000234,834,000

Income Statement (P&L) (USD)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
Operating expenses(19,934,000)(22,789,000)(27,879,000)(28,777,000)(26,512,000)(20,937,000)
Operating loss:(19,934,000)(22,789,000)(27,879,000)(28,777,000)(26,512,000)(20,937,000)
Nonoperating income
(Other Nonoperating income)
160,000291,000223,000203,000190,000249,000
Net loss:(19,774,000)(22,498,000)(27,656,000)(28,574,000)(26,322,000)(20,688,000)
Other undisclosed net income attributable to parent44,817,0001,579,0002,005,0002,198,0002,051,0001,554,000
Net income (loss) attributable to parent:25,043,000(20,919,000)(25,651,000)(26,376,000)(24,271,000)(19,134,000)
Preferred stock dividends and other adjustments (43,792,000)     
Net income (loss) available to common stockholders, basic:(18,749,000)(20,919,000)(25,651,000)(26,376,000)(24,271,000)(19,134,000)
Dilutive securities, effect on basic earnings per share (43,792,000)     
Other undisclosed net income available to common stockholders, diluted 43,792,000     
Net income (loss) available to common stockholders, diluted:(18,749,000)(20,919,000)(25,651,000)(26,376,000)(24,271,000)(19,134,000)

Comprehensive Income (USD)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
Net loss:(19,774,000)(22,498,000)(27,656,000)(28,574,000)(26,322,000)(20,688,000)
Comprehensive loss, net of tax, attributable to parent:(19,774,000)(22,498,000)(27,656,000)(28,574,000)(26,322,000)(20,688,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: